MYBL1
Myb-related protein A
Also known as: A-myb, AMYB, MYBA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10243
- Gene
- MYBL1
- Ensembl
- ENSG00000185697
- Chromosome
- 8
- Canonical length
- 752 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
752 residues, UniProt reviewed canonical sequence.
>P10243|MYBL1
1 MAKRSRSEDE DDDLQYADHD YEVPQQKGLK KLWNRVKWTR DEDDKLKKLV EQHGTDDWTL
61 IASHLQNRSD FQCQHRWQKV LNPELIKGPW TKEEDQRVIE LVQKYGPKRW SLIAKHLKGR
121 IGKQCRERWH NHLNPEVKKS SWTEEEDRII YEAHKRLGNR WAEIAKLLPG RTDNSIKNHW
181 NSTMRRKVEQ EGYLQDGIKS ERSSSKLQHK PCAAMDHMQT QNQFYIPVQI PGYQYVSPEG
241 NCIEHVQPTS AFIQQPFIDE DPDKEKKIKE LEMLLMSAEN EVRRKRIPSQ PGSFSSWSGS
301 FLMDDNMSNT LNSLDEHTSE FYSMDENQPV SAQQNSPTKF LAVEANAVLS SLQTIPEFAE
361 TLELIESDPV AWSDVTSFDI SDAAASPIKS TPVKLMRIQH NEGAMECQFN VSLVLEGKKN
421 TCNGGNSEAV PLTSPNIAKF STPPAILRKK RKMRVGHSPG SELRDGSLND GGNMALKHTP
481 LKTLPFSPSQ FFNTCPGNEQ LNIENPSFTS TPICGQKALI TTPLHKETTP KDQKENVGFR
541 TPTIRRSILG TTPRTPTPFK NALAAQEKKY GPLKIVSQPL AFLEEDIREV LKEETGTDLF
601 LKEEDEPAYK SCKQENTASG KKVRKSLVLD NWEKEESGTQ LLTEDISDMQ SENRFTTSLL
661 MIPLLEIHDN RCNLIPEKQD INSTNKTYTL TKKKPNPNTS KVVKLEKNLQ SNCEWETVVY
721 GKTEDQLIMT EQARRYLSTY TATSSTSRAL ILLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYBL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 19 nTPM
- tonsil: 15 nTPM
- testis: 11 nTPM
- blood vessel: 8.6 nTPM
- spleen: 7.1 nTPM
- appendix: 5.8 nTPM
Single-cell type
- nk-cells: 260 nCPM
- t-cells: 171 nCPM
- cardiomyocytes: 62 nCPM
- innate lymphoid cells: 58 nCPM
- early primary spermatocytes: 49 nCPM
- late primary spermatocytes: 28 nCPM
Immune cell
- gdT-cell: 1.9 nTPM
- MAIT T-cell: 1.3 nTPM
- memory CD8 T-cell: 0.8 nTPM
- NK-cell: 0.6 nTPM
- memory CD4 T-cell: 0.3 nTPM
- naive CD8 T-cell: 0.3 nTPM
Brain region
- white matter: 8.8 nTPM
- pons: 8 nTPM
- medulla oblongata: 6.3 nTPM
- basal ganglia: 5.8 nTPM
- cerebellum: 5.6 nTPM
- spinal cord: 5.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.08
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.13
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- male meiosis I
- mitotic cell cycle
- positive regulation of DNA-templated transcription
- positive regulation of transcription by RNA polymerase II
- spermatogenesis
- positive regulation of piRNA transcription
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MYBL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYBL1 as an antibody target. Whether an autoantibody or antibody against MYBL1 could matter depends on whether native MYBL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYBL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYBL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...